Delivery Order SPE2DB25D3020-SPE2DB25FWKAZ
- Not listed
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) valued at $33,841.22 under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Citalopram HBr 20 mg tablets (500-count) with a ceiling value of $3,132.17. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Citalopram HBr 20 mg tablets (500 count) valued at $1,582.47. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Citalopram HBR 40 mg, a selective serotonin reuptake inhibitor commonly used to treat depression and anxiety disorders. This firm fixed price delivery order, valued at $8,197.49, was competitively awarded without a set-aside designation and carries an ultimate completion date of August 13, 2025. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency Troop Support Medical awarded a $69,110 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 10 mg citalopram hydrobromide (CITALOPRAM HBR) to be delivered to its Conshohocken, Pennsylvania facility by August 28, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division location. The Defense Logistics Agency supports Department of Defense procurement and supply chain...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a $392,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 40mg tablets of citalopram hydrobromide. The one-day contract has a period of performance from July 25, 2023 through July 26, 2023, with all work taking place in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for a generic antidepressant medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units, with a ceiling value of $13,316.99 and a firm fixed price structure. This is a non-set-aside contract, indicating the award was made through open competition. The delivery order is expected to be completed by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKAZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,158.43 to AmerisourceBergen Drug Corp for 500 tablets of Citalopram HBR 40 mg. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, due for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Citalopram is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and is a standard pharmaceutical in military medical supply chains. This delivery order represents a routine pharmaceutical procurement from AmerisourceBergen's extensive portfolio of medical product deliveries to federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's consistent awards through open competition and its role as a primary pharmaceutical vendor underscore its strategic importance to DLA's medical supply chain operations supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/15/25 |